LifeStance Health Group Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
LFST$14.56-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits, Financial Statement Schedules
(a)
The following documents are filed as part of this Annual Report on Form 10-K:
Financial Statements
The following financial statements and schedules of the Registrant are contained in Part II, Item 8, "Financial Statements and Supplementary Data" of this Annual Report on Form 10-K:
| Page | |
| Report of Independent Registered Public Accounting Firm | F-2 |
|---|---|
| Consolidated Financial Statements: | |
| Consolidated Balance Sheets | F-4 |
| Consolidated Statements of Operations and Comprehensive Loss | F-5 |
| Consolidated Statements of Changes in Stockholders' Equity | F-6 |
| Consolidated Statements of Cash Flows | F-7 |
| Notes to the Consolidated Financial Statements | F-8 |
List of Financial Statement Schedules.
All schedules are omitted because the required information is either not present, not present in material amounts or presented within the consolidated financial statements.
(b)
The exhibits listed in the following “Exhibits Index” are filed, furnished or incorporated by reference as part of this Annual Report.
Exhibit Index
| Description of Exhibit Incorporated Herein by Reference | ||||||
|---|---|---|---|---|---|---|
| ExhibitNumber | Description | Form | File No. | Exhibit | Filing Date | Filed Herewith |
| 3.1 | Amended and Restated Certificate of Incorporation of LifeStance Health Group, Inc. | 8-K | 001-40478 | 3.1 | 6/15/2021 | |
| 3.2 | Second Amended and Restated Bylaws of LifeStance Health Group, Inc. | 8-K | 001-40478 | 3.1 | 3/9/2023 | |
| 4.1 | Form of Common Stock Certificate | S-1/A | 333-256202 | 4.1 | 6/1/2021 | |
| 4.2 | Description of Securities | 10-K | 001-40478 | 4.2 | 3/17/2022 | |
| 10.1 | Registration Rights Agreement, dated as of June 9, 2021, by and among the Company and each of the other persons from time to time party thereto | 8-K | 001-40478 | 10.1 | 6/15/2021 | |
| 10.2 | Stockholders Agreement, dated as of June 9, 2021, by and among the Company and each of the other persons from time to time party thereto | 8-K | 001-40478 | 10.2 | 6/15/2021 | |
| 10.3+ | Employment Agreement, dated September 7, 2022, between LifeStance Health Group, Inc. and Kenneth Burdick | 10-Q | 001-40478 | 10.8 | 11/9/2022 | |
| 10.4+ | Amended and Restated Employment Agreement, dated May 14, 2020, between LifeStance Health, Inc. and Danish Qureshi | S-1 | 333-256202 | 10.9 | 5/17/2021 | |
| 10.5+ | Letter Agreement, dated September 7, 2022, between LifeStance Health Group, Inc. and Danish Qureshi | 10-Q | 001-40478 | 10.9 | 11/9/2022 | |
| 10.6+ | Employment Agreement, dated as of November 2, 2022, between LifeStance Health Group, Inc. and David Bourdon | 10-K | 001-40478 | 10.30 | 3/9/2023 | |
| 10.7+ | LifeStance Health Group, Inc. 2021 Equity Incentive Plan | 8-K | 001-40478 | 10.4 | 6/15/2021 | |
| 10.8+ | LifeStance Health Group, Inc. 2021 Employee Stock Purchase Plan | 8-K | 001-40478 | 10.5 | 6/15/2021 | |
| 10.9+ | LifeStance Health Group, Inc. 2021 Cash Incentive Plan | 8-K | 001-40478 | 10.6 | 6/15/2021 | |
| 10.10 | Form of Indemnification Agreement between LifeStance Health Group, Inc. and each of its directors and executive officers | S-1 | 333-256202 | 10.17 | 5/17/2021 | |
| 10.11 | Form of Management Services Agreement with Supported Practices | S-1 | 333-256202 | 10.19 | 5/17/2021 | |
| 10.12+ | Form of RSU Agreement under the 2021 Plan | S-1/A | 333-256202 | 10.12 | 6/1/2022 | |
| 10.13+ | Form of Notice of Amended Award Terms for Class B Unit Award Agreement | S-1/A | 333-256202 | 10.13 | 6/1/2022 | |
| 10.14+ | Form of Non-Qualified Stock Option Agreement | 10-Q | 001-40478 | 10.10 | 11/9/2022 | |
| 10.15+ | Form of RSU Agreement (Time) (Sell to Cover) under the 2021 Plan | 10-K | 001-40478 | 10.28 | 3/9/2023 | |
| 10.16+ | Form of RSU Agreement (Time and Performance) (Sell to Cover) under the 2021 Plan | 10-K | 001-40478 | 10.29 | 3/9/2023 | |
| 10.17+ | Severance and Change in Control Policy | 10-Q | 001-40478 | 10.6 | 8/10/2022 | |
| 10.18+ | Separation and Release of Claims Agreement, dated as of June 30, 2024, between LifeStance Health Group, Inc. and Danish Qureshi | 10-Q | 001-40478 | 10.2 | 8/8/2024 | |
| 10.19 | Credit Agreement, dated as of December 19, 2024, among LifeStance Health Holdings, Inc., Lynnwood Intermediate Holdings, Inc., and Capital One, National Association | X | ||||
| 19.1 | LifeStance Health Group, Inc. Insider Trading Policy | X | ||||
| 21.1 | List of subsidiaries of LifeStance Health Group, Inc. | X | ||||
| 23.1 | Consent of PricewaterhouseCoopers LLP | X | ||||
| 31.1 | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | ||||
| Description of Exhibit Incorporated Herein by Reference | |||||
|---|---|---|---|---|---|
| ExhibitNumber · Description · Form · File No. · Exhibit · Filing Date · Filed Herewith | |||||
| 31.2 · Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. · X | |||||
| 32.1 · Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. · X | |||||
| 32.2 · Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. · X | |||||
| 97.1 | LifeStance Health Group, Inc. Policy for Recoupment of Incentive Compensation | 10-K | 001-40478 | 97.1 | 2/28/2024 |
| 101.INS | Inline XBRL Instance Document | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Document | ||||
| 104 | The Cover page from the Annual Report on Form 10-K of LifeStance Health Group, Inc. for the year ended December 31, 2024 formatted in Inline XBRL | ||||
+Indicates a management contract or compensatory plan, contract or arrangement.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.